Changes in body weight and behavior of pregnant females during the gestation period
Following CYP treatment during the gestation period, no evident adverse symptoms were observed in the lower dose (25 mg) group females. However, mild nausea, irritability and salivation were observed during the last days of gestation. In the 50 mg and 75 mg groups, pregnant females showed less intake of food and water, diarrhoea, respiratory distress and a tilted neck. The observed signs of toxicity in the current study show similarity with the results of previous study (
Madu, 2015). Similar results were also noted in the study of
Ramon-Yusuf et al. (2017) where rats were treated in combination with cypermethrin and dimethoate.
Pregnant females of the control groups showed a significant increase in weight during the gestation period throughout the experiment. However, CYP-treated pregnant females of all experimental groups showed less gain in body weight during the gestation period than control group. 75 mg CYP treated group showed a lesser gain in weight as compared to the lower dose treated group (Fig 1). Mortality was also observed in the 75 mg dose group.
Joya and Sangha (2016) also reported less gain in body weight in pregnant females treated with 0.1 mg/kg of deltamethrin. Similar results were noted in the study of
Madu (2015).
Growth and developmental study of pups
Control group pups showed a significant increase in their body weight and length. At post-natal day (PND) 5, 20, 25 and 30, the higher dose (75 mg CYP) exposed group exhibited a significant (p<0.05) reduction in their body weight from the control group (Fig 2A). 50 mg and 75 mg CYP exposed group denoted a significant (p<0.05) decrease in their body length from the control group (Fig 2B). CYP treated group showed a lesser gain in their body weight and length. The growth and developmental findings of the current investigation were consistent with the results of previous studies (
Joya and Sangha, 2016;
Madu, 2015;
Savithri et al., 2014). The body fur arrival time and opening of the eyes were found slightly delayed in the treated group as compared to the control group. 75 mg CYP treated group pups’eye-opening and fur arrival time was also found significantly different (p<0.01) from the control and 25 mg CYP group (Fig 2C). A significant delay in developmental landmarks after deltamethrin exposure was also noted in previous studies (
Joya and Sangha, 2016;
Lazarini, 2001). The growth of 75 mg CYP-treated female pups was comparatively less than the lower dose-treated groups. Body texture, size and behavioral activity were also different in the CYP-exposed group compared to the control group. Mortality was also reported in the experimental group’s pups, this parameter was recorded as high in the 75 mg CYP-treated group and at some extant in the 50 mg group. The observed mortality of the offspring was found to be similar to the findings of
(Savithri et al., 2014).
Learning and memory study using MWM
From the results of the MWM task, it was observed that the performance of the control group pups was better than CYP-treated group pups.
In the spatial acquisition test, less time was taken by the control group pups to reach the platform as compared to CYP-treated group pups (Fig 3A). Reference memory data of the spatial test showed that the control group pups spent more time in the platform area than the CYP-treated group pups which means that the control group pups remember the position of the platform than the CYP-treated group pups (Fig 3B).
Similarly, in reversal spatial tasks better performance was noticed in the case of the control group than in CYP-treated groups (Fig 4A). In the case of experimental groups, 25 mg CYP group performs far better than the 50 and 75 mg group pups.Reference memory data also proved the same thing that controls and 25 mg group pups were able to memorize the position of the platform than the 50 and 75 mg CYP group pups (Fig 4B).
In the discrimination learning test, pups have to differentiate between true (static) and false (floating) goals. From the data, it was observed that the control group pups chose a static platform over a floating platform in most trials but CYP-treated pups chose more floating trials as compared to the control group pups (Fig 5C). On 1st day of the trial, all group pups take more time to reach the goal but on the last or 5th day of the trial control and 25 mg group pups take lesser time to reach the goal than 50 mg and 75 mg group pups (Fig 5A). Reference memory data also revealed that control group pups also spent more time in the static platform quadrant than experimental group pups (Fig 5B).
In the latent learning task, pups were placed on the platform for 5-10 seconds before each trial so that pups remember the location of the platform. However, it was observed that the 50 mg and 75 mg group pups performed poorly even after placing the pups on the platform before starting the trials. The performance of the control and 25 mg group was comparable in this task (Fig 6A). Reference memory data explained that the control group pups remember both the platform position (SW as well as NE) because control pups spent approximately equal time in both directions but CYP-treated pups significantly (p<0.001) spent more time in the NE direction than SW as in the last 2 days of task platform was located in NE direction so CYP treated group pups able to build up only short memory than control group pups. Time spent by the treatment group in the SW quadrant showed a highly significant (p <0.0001) difference from the control group pups (Fig 6B).
In trial-dependent working and spatial learning and memory tasks, the control group demonstrated superior performance. The 25 mg group’s performance was likewise similar to that of control group but 50 mg and 75 mg treated groups performed poorly in this task. They take more time to reach the successive goal than the control and 25 mg CYP group (Fig 7). From the data of Morris water maze task, it was observed that CYP treatment affects the learning and memory of pups.
Terry et al., (2003) and
Yan et al., (2012) also discovered that rats’ performance on a spatial learning task was compromised following the treatment to Chlorpyrifos. A mixture of endosulfan and methyl parathion exposure leads to increased latency in searching the platform by the rats
(Castillo et al., 2002). In the previous studies, it is clearly stated that CYP exposure leads to nervous toxicity caused by oxidative stress and the generation of free radicals which harms the brain’s cellular structure. So, the hippocampus is the crucial component of the brain that plays a vital role in learning and memory and injury to the hippocampus leads to the destruction of the memory. The impairment in learning and memory tasks of the treated group could be due to impairment in the hippocampus region of the central nervous system
(Lu et al., 2021). Rastegar-Moghaddam et al. (2018) was also in agreement with our study by stating that atrazine-treated groups spent more time reaching the platform and also remained for less time in the target quadrant as compared to the control group. Similar results were also observed in the study of
Zhang et al., (2019) where propamocarb fungicide-treated mice spent less time in the target zone and had poor memory. According to
Nishiyori et al., (2014) a lady who attempted suicide after ingesting pesticides had anxiety and short-term memory problems, which is consistent with our findings. Additionally, rats exposed to permethrin demonstrated a marked decline in their short-term memory and spatial orientation
(Nasuti et al., 2003). Beta-cyfluthrin was found to impair both motor coordination and spatial memory
(Syed et al., 2016). According to the current research, animals’ ability to learn and remember things is adversely affected by CYP exposure, which is consistent with findings by
Gargouri et al., (2018). Ozdemir et al., (2014) found that offspring exposed to clothianidin exhibit low performance in the MWM task, which is in line with the current investigation. The prenatal exposure to melamine also damaged the cognitive abilities of rats. Similar results were also reported in the previous studies (
Ghasemnejad-Berenji et al., 2021;
Maodaa et al., 2024; Murshed et al., 2023; Wasnik et al., 2023). Xie et al., (2023) validated the current investigation by exposing the rats to three different doses (6.25 mg, 12.5 mg and 25 mg/kg) of cyfluthrin and observed a reduction in the spatial learning and memory abilities of rats. According to
Imam et al., (2018), rats exposed to dichlorvos and chlorpyrifos for 14 days may have neurocognitive impairments and exhibit more anxiety-like behaviors.